HomeLatest Pharma-News

Latest Pharma-News

Latest Pharma-News

J&J announced Icotrokinra results show 75% of adolescents with plaque psoriasis achieved completely clear skin

admin - April 11, 2025

Latest Pharma-News

Sanofi’s Tolebrutinib phase 3 data published in NEJM demonstrate benefit on disability progression in multiple sclerosis

admin - April 9, 2025

Latest Pharma-News

Novartis receives FDA accelerated approval for Vanrafia for proteinuria reduction in primary IgA nephropathy

admin - April 9, 2025

Latest Pharma-News

AstraZeneca showcases innovation in infectious disease protection at ESCMID Global 2025

admin - April 9, 2025

Latest Pharma-News

FDA Alerts Patients of Potential to Miss Critical Safety Alerts Due to Phone Settings When Using Smartphone-Compatible Diabetes Devices

admin - February 10, 2025

Latest Pharma-News

Lopinavir/Ritonavir, Umifenovir Ineffective for Mild COVID-19

admin - April 24, 2020 0

Latest Pharma-News

Novartis announces data showing Jakavi® (ruxolitinib) more effective than best available therapy in acute graft-versus-host disease

admin - April 23, 2020 0

Latest Pharma-News

AstraZeneca and Saint Luke’s Mid America Heart Institute initiate Phase III DARE-19 trial with Farxiga in COVID-19 patients

admin - April 23, 2020 0

Latest Pharma-News

WHO reports fivefold increase in cyber attacks, urges vigilance

admin - April 23, 2020 0

Latest Pharma-News

TearLab Resubmits 510(k) for U.S. FDA Clearance of the TearLab Discovery™ MMP-9 Test

admin - April 23, 2020 0

Latest Pharma-News

Michigan AG Nessel Leads Coalition in Asking Congress to Regulate Prices of Medical Supplies, Equipment During COVID-19 Pandemic

admin - April 23, 2020 0

Latest Pharma-News

Attorney General Nessel Sends Letter Urging FDA to Base Blood Donation Restrictions on Risk, Not Sexual Orientation

admin - April 23, 2020 0

Latest Pharma-News

FDA grants accelerated approval to sacituzumab govitecan-hziy for metastatic triple negative breast cancer

admin - April 23, 2020 0

Latest Pharma-News

Johnson & Johnson and AbbVie Receives 11th FDA Approval for IMBRUVICA® (ibrutinib)

admin - April 23, 2020 0

Latest Pharma-News

Mallinckrodt Announces U.S. FDA Filing Acceptance of New Drug Application for Terlipressin for Treatment of Hepatorenal Syndrome Type 1 (HRS-1)

admin - April 23, 2020 0

Latest Pharma-News

Novartis Kymriah® receives FDA Regenerative Medicine Advanced Therapy designation in follicular lymphoma

admin - April 23, 2020 0

Latest Pharma-News

Confirmation of COVID-19 in Two Pet Cats in New York

admin - April 23, 2020 0

1...119120121...145 Page 120 of 145

Most Read

J&J announced Icotrokinra results show 75% of adolescents with plaque psoriasis achieved completely clear skin

April 11, 2025

Sanofi’s Tolebrutinib phase 3 data published in NEJM demonstrate benefit on disability progression in multiple sclerosis

April 9, 2025

Novartis receives FDA accelerated approval for Vanrafia for proteinuria reduction in primary IgA nephropathy

April 9, 2025

AstraZeneca showcases innovation in infectious disease protection at ESCMID Global 2025

April 9, 2025

EDITOR PICKS

Job Interview Questions for Clinical Data Management 2024

August 14, 2021

CRASH COURSE ON CLINICAL DATA MANAGEMENT

November 24, 2020

Interview Questions on Institutional Review Board(IRB)

August 27, 2020

POPULAR POSTS

How to Find Paid Clinical Trials Near You

January 2, 2023

What Is CDISC and What Are CDISC Data Standards?

May 17, 2022

What is Dechallenge, Rechallenge and Prechallenge in Clinical trials?

August 5, 2021

ABOUT US

LifeProNow provides guidance and high quality contents to help job seekers to get their dream Job. All the contents are written by experienced folks and peer reviewed by experts.

Contact us: [email protected]

FOLLOW US

© LifeProNow | All Rights Reserved